Clinical Trials

DermatologicEndocrineGenitourinaryThoracic

96 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT06219902 2024-05-08

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

64 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT03470259 2024-04-16

TARGET

19 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

NCT04373265 2024-02-23

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

15 enrolled

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, Diabetes Mellitus, Type 2, Endocrine System Diseases, Hyperglycemia, Hypertension, Pathologic Processes, Glucose Intolerance, Adrenocortical Carcinoma

NCT03780517 2023-10-30

Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors

117 enrolled

EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Medullary, Multiple Endocrine Neoplasia Type 2a

NCT04845841 2023-08-09

Comparison of the Extent to Which the Drug Given as Two Different Capsule Sizes Becomes Available to the Body

Multiple Endocrine Neoplasia Type 1

NCT04889287 2023-08-09

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Multiple Endocrine Neoplasia Type 1

NCT05481528 2023-05-09

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

51 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT04212793 2023-04-14

DEPARTURE

20 enrolled

Pituitary Neoplasms

NCT03517488 2022-12-01

DUET-2

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

150 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Anus Neoplasms, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Melanoma, Mesothelioma, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Thymoma, Thymus Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05471817 2022-11-22

A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

20 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT04470843 2022-09-23

Impact of Acetazolamide in Reducing Referred Postoperative Pain

33 enrolled

EndocrineGenitourinary

Pain, Postoperative, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT05381142 2022-07-27

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

15 enrolled

CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

NCT05351892 2022-07-19

A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

18 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT03122496 2022-06-08

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

13 enrolled

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT03411915 2022-05-10

DUET-1

EndocrineGastrointestinalNET

62 enrolled

Gastrointestinal Neoplasms, Neuroendocrine Tumors

NCT03147768 2022-04-06

LTW

EndocrineGastrointestinal

11 enrolled

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms, Pancreatic Pseudocyst

NCT04981431 2022-03-29

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

62 enrolled

Multiple Endocrine Neoplasia Type 1

NCT04903821 2022-03-24

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

33 enrolled

Multiple Endocrine Neoplasia Type 1

NCT05061563 2022-03-17

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

14 enrolled

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT05028608 2022-02-25

A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.

Multiple Endocrine Neoplasia Type 1

NCT01218555 2022-01-27

Study of Everolimus (RAD001) in Combination With Lenalidomide

EndocrineGenitourinaryNET

44 enrolled 9 charts

Kidney Neoplasms, Neuroendocrine Tumors

NCT01772004 2021-12-20

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

1,756 enrolled 59 charts

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT03361384 2021-07-23

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

260 enrolled

Alcohol Drinking, Homosexuality, Sexual Behavior, Multiple Endocrine Neoplasia Type 1

NCT00446082 2020-12-21

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

85 enrolled

Acromegaly, Carcinoid Tumor

NCT01263353 2020-12-21

COOPERATE-1

36 enrolled

Carcinoid Tumor

NCT01364415 2020-12-21

Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)

29 enrolled

Neuroendocrine Tumors

NCT02355535 2020-09-24

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1

48 enrolled

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT03883776 2020-09-09

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

12 enrolled

Neuroendocrine Tumors

NCT01970540 2020-03-09

Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors

122 enrolled 19 charts

Neoplasms, Neuroendocrine Tumors

NCT03154086 2019-08-09

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

68 enrolled 80 charts

Multiple Endocrine Neoplasia Type 2a, Irritable Bowel Syndrome

NCT03167853 2019-06-21

Study of JS001 in Patients With Advanced Neuroendocrine Tumors

40 enrolled

Neuroendocrine Tumors

NCT00870779 2019-06-14

FGR

105 enrolled

CNSEndocrine

Brain Neoplasms, Glioma, Meningioma, Pituitary Neoplasms, Skull Base Neoplasms

NCT01590199 2019-04-16

MACS2002

18 enrolled

Neuroendocrine Tumors

NCT01682746 2019-02-25

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

5 enrolled

CNSEndocrineSarcoma

Astrocytoma, Brain Neoplasms, Chordoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Oligodendroglioma, Pituitary Neoplasms, Germinoma, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Optic Nerve Glioma

NCT02267967 2018-11-13

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

81 enrolled

Neuroendocrine Tumors

NCT00926640 2018-10-19

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

28 enrolled

EndocrineThoracic

Carcinoma, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT01469572 2018-10-18

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

EndocrineGastrointestinalNET

13 enrolled

Liver Neoplasms, Neuroendocrine Tumors

NCT02063958 2018-07-30

Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors

19 enrolled

Neoplasms, Neuroendocrine Tumors

NCT01898715 2017-11-06

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

63 enrolled